Global Blood Therapeutics, Inc. (GBT) financial statements (2021 and earlier)

Company profile

Business Address 181 OYSTER POINT BLVD
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments495418385316302268338
Cash and cash equivalents495418385316302268338
Receivables18141253  
Inventory, net of allowances, customer advances and progress billings403427151  
Inventory403427151  
Prepaid expense13   9  
Other undisclosed current assets67128170229312348328
Total current assets:632595594564628616667
Noncurrent Assets
Operating lease, right-of-use asset515152525314 
Property, plant and equipment38394037271412
Restricted cash and investments2222222
Other noncurrent assets1110110
Other undisclosed noncurrent assets 33384858087
Total noncurrent assets:9297128177168112102
TOTAL ASSETS:724691722741796727769
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities74736660704038
Accounts payable1986141177
Accrued liabilities31474435412223
Employee-related liabilities2418161118108
Other liabilities5543211
Total current liabilities:79786962714140
Noncurrent Liabilities
Long-term debt and lease obligation22815415615514624 
Long-term debt, excluding current maturities14974747474  
Operating lease, liability798082827224 
Liabilities, other than long-term debt111 041
Other liabilities111 041
Other undisclosed noncurrent liabilities      24
Total noncurrent liabilities:2291561561551462825
Total liabilities:3082342262182176965
Stockholders' equity
Stockholders' equity attributable to parent416458496524579658704
Common stock0000000
Additional paid in capital1,4021,3821,3591,3341,3171,3001,281
Accumulated other comprehensive income0111111
Accumulated deficit(986)(925)(865)(812)(739)(643)(578)
Total stockholders' equity:416458496524579658704
TOTAL LIABILITIES AND EQUITY:724691722741796727769

Income statement (P&L) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Revenues413732142  
Cost of revenue
(Cost of Goods and Services Sold)
(1)(1)(0)(0)   
Gross profit:40363114   
Operating expenses(101)(95)(83)(87)(110)(69)(61)
Other undisclosed operating income1   10  
Operating loss:(59)(58)(52)(73)(99)(69)(61)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(2)(2)(1)0 43
Interest and debt expense(23)  (30)   
Other undisclosed loss from continuing operations before equity method investments, income taxes    (42)  
Loss from continuing operations before equity method investments, income taxes:(85)(60)(53)(103)(142)(65)(57)
Other undisclosed income from continuing operations before income taxes49   46  
Net loss:(36)(60)(53)(103)(96)(65)(57)
Other undisclosed net income (loss) attributable to parent(26)  30(0)  
Net loss available to common stockholders, diluted:(62)(60)(53)(73)(96)(65)(57)

Comprehensive Income ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Net loss:(36)(60)(53)(103)(96)(65)(57)
Comprehensive loss:(36)(60)(53)(103)(96)(65)(57)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(27)(1)030(0)(0)1
Comprehensive loss, net of tax, attributable to parent:(62)(60)(53)(73)(96)(65)(57)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: